Calidi Biotherapeutics Inc.
Organization details
- Legal name
- Calidi Biotherapeutics Inc.
- Former names
- First Light Acquisition Group, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CLDI
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001855485
- EIN
- 86-2967193
Board of directors
-
Alan R. Stewart · DirectorSince 2023
-
Alfonso G. Zulueta · DirectorSince 2024
-
Allan Camaisa · Director · CEO and Chairman of the BoardSince 2023
-
Corazon (Corsee) D. Sanders · DirectorSince 2026
-
David LaPre · DirectorSince 2024
-
Eric E. Poma · Director · Chief Executive OfficerSince 2025
-
George K. Ng · DirectorSince 2023
-
George Peoples · DirectorSince 2024
-
Heehyoung Lee · DirectorSince 2023
-
James A. Schoeneck · DirectorSince 2023
-
Scott Leftwich · DirectorSince 2023
-
Thomas A. Vecchiolla · DirectorSince 2023
Chief executives
Director election results
Annual meeting of July 9, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.9%
-
86.4%
Board connections
4 of this board's directors also sit on 8 other boards. 7 are in the same sector.
-
BeOne Medicines Ltd. Same sectorvia Corazon (Corsee) D. Sanders
- via Alfonso G. Zulueta
-
Connect Biopharma Holdings Limited Same sectorvia James A. Schoeneck
-
Kyntra Bio Inc. Same sectorvia James A. Schoeneck
-
Legend Biotech Corporation Same sectorvia Corazon (Corsee) D. Sanders
-
Processa Pharmaceuticals Inc. Same sectorvia George K. Ng
-
TuHURA Biosciences Inc. Same sectorvia George K. Ng
-
Ultragenyx Pharmaceutical Inc. Same sectorvia Corazon (Corsee) D. Sanders
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,241
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Allan Camaisa Director | Open-market sale | −850 | $1.46 | $1,241 |
| Aug 21, 2025 | Jackson Andrew C. Officer (Chief Financial Officer) | Open-market purchase | +2,500 | $2.00 | $5,000 |
| Aug 21, 2025 | Scott Leftwich Director | Open-market purchase | +125,000 | $2.00 | $250,000 |
| Aug 21, 2025 | Eric E. Poma Director, Officer (Chief Executive Officer) | Open-market purchase | +25,000 | $2.00 | $50,000 |
| Aug 21, 2025 | James A. Schoeneck Director | Open-market purchase | +75,000 | $2.00 | $150,000 |
| Dec 31, 2024 | Alan R. Stewart Director | Grant or award | +12,771 | — | — |
| Dec 31, 2024 | Scott Leftwich Director | Grant or award | +11,684 | — | — |
| Dec 17, 2024 | Allan Camaisa Director, Officer (CEO and Chairman of the Board) | Open-market sale | −10,000 | $1.62 | $16,200 |
| Sep 26, 2024 | Allan Camaisa Director, Officer (CEO and Chairman of the Board), 10% owner | Grant or award | +70,155 | $1.15 | $80,678 |
| Jun 28, 2024 | Scott Leftwich Director | Grant or award | +67,187 | — | — |
| Jun 28, 2024 | James A. Schoeneck Director | Grant or award | +79,687 | — | — |
| Jun 28, 2024 | Alan R. Stewart Director | Grant or award | +73,437 | — | — |
| Jun 3, 2024 | James A. Schoeneck Director | Option exercise | +173,000 | $0.20 | $34,600 |
| Jun 3, 2024 | James A. Schoeneck Director | Option exercise | +375,000 | $0.20 | $75,000 |
| Apr 18, 2024 | James A. Schoeneck Director | Grant or award | +375,000 | $0.40 | $150,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Calidi Biotherapeutics Inc.
Who is the CEO of Calidi Biotherapeutics Inc.?
Eric E. Poma has been Calidi Biotherapeutics Inc.'s Chief Executive Officer since April 2025.
How many directors are on Calidi Biotherapeutics Inc.'s board?
Calidi Biotherapeutics Inc.'s board has 12 directors: Alan R. Stewart, Alfonso G. Zulueta, Allan Camaisa, Corazon (Corsee) D. Sanders, David LaPre, Eric E. Poma, George K. Ng, George Peoples, Heehyoung Lee, James A. Schoeneck and 2 others.
Are Calidi Biotherapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Calidi Biotherapeutics Inc. insiders made no open-market purchases and sold $1,241 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="calidi-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.